This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


BioMarin Pharmaceutical Inc.

Drug Names(s): Neutralase

Description: Neutralase, or heparinase I, is a carbohydrate-modifying enzyme that cleaves heparin and inactivates it. It is a potential alternative to protamine sulfate used currently to reverse heparin-induced anti-coagulation during coronary artery bypass grafting (CABG).

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug